ABILIFY MAINTENA Trademark

Trademark Overview

On Monday, June 17, 2013, a trademark application was filed for ABILIFY MAINTENA with the United States Patent and Trademark Office. The USPTO has given the ABILIFY MAINTENA trademark a serial number of 79133706. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Wednesday, March 24, 2021. This trademark is owned by Otsuka Pharmaceutical Co., Ltd.. The ABILIFY MAINTENA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system diseases and disorders
abilify maintena

General Information

Serial Number79133706
Word MarkABILIFY MAINTENA
Filing DateMonday, June 17, 2013
Status709 - CANCELLED - SECTION 71
Status DateWednesday, March 24, 2021
Registration Number4496718
Registration DateTuesday, March 18, 2014
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 31, 2013

Trademark Statements

Description of MarkThe mark consists of a stylized blue letter "A" in front of a blue winding road design with a gold line in the middle of the road design with a blue line extending left and right of the letter "A", all above the words "ABILIFY MAINTENA" with the word "ABILIFY" appearing in the color blue and "MAINTENA" appearing in the color gold.
Goods and ServicesPharmaceutical preparations for the treatment of central nervous system diseases and disorders
Indication of Colors claimedThe color(s) blue and gold is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateWednesday, March 24, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOTSUKA PHARMACEUTICAL CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressChiyoda-ku, Tokyo 1018535
JP
Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressChiyoda-ku, Tokyo 1018535
JP
Party NameOtsuka Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChiyoda-ku, Tokyo 1018535
JP

Trademark Events

Event DateEvent Description
Thursday, May 25, 2023INTERNATIONAL REGISTRATION RENEWED
Tuesday, March 21, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 13, 2023GENERIC MADRID TRANSACTION SENT TO IB
Friday, January 13, 2023INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Thursday, January 12, 2023GENERIC MADRID TRANSACTION CREATED
Monday, June 27, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, November 24, 2021TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sunday, July 11, 2021REFUSAL PROCESSED BY IB
Thursday, March 25, 2021NOTICE OF CANCELLATION SEC. 71 E-MAILED
Wednesday, March 24, 2021CANCELLED SECTION 71
Wednesday, September 23, 2020POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Friday, September 18, 2020TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Wednesday, March 18, 2020POST REGISTRATION ACTION MAILED - SEC. 71 & 15
Thursday, March 12, 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, January 27, 2020TEAS SECTION 71 & 15 RECEIVED
Monday, March 18, 2019COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, August 28, 2014CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, July 22, 2014FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, June 20, 2014FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 20, 2014FINAL DISPOSITION PROCESSED
Wednesday, June 18, 2014FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, March 18, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, December 31, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 31, 2013PUBLISHED FOR OPPOSITION
Monday, December 30, 2013NOTIFICATION PROCESSED BY IB
Wednesday, December 11, 2013NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, December 11, 2013NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 11, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 22, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, November 19, 2013ASSIGNED TO LIE
Wednesday, October 30, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 29, 2013TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 28, 2013CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 28, 2013TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 15, 2013REFUSAL PROCESSED BY IB
Tuesday, September 24, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 24, 2013REFUSAL PROCESSED BY MPU
Tuesday, September 24, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 23, 2013NON-FINAL ACTION WRITTEN
Wednesday, September 18, 2013ASSIGNED TO EXAMINER
Tuesday, August 13, 2013APPLICATION FILING RECEIPT MAILED
Friday, August 9, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 9, 2013LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, August 8, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

maintena abilify system diseases disorders nervous central preparations treatment pharmaceutical